Table 4. Comparison of NLR and PLR at diagnosis, after four cycles of chemotherapy and at disease progression.
| Factors | At diagnosis | After 4 cycles | p | After 4 cycles | Progression | p |
|---|---|---|---|---|---|---|
| Sensitive | ||||||
| NLR | 3.83 ± 2.31 | 2.45 ± 1.67 | < 0.001 | 2.45 ± 1.67 | 4.12 ± 2.49 | < 0.001 |
| PLR | 178.68 ± 95.34 | 170 ± 95.31 | 0.335 | 170 ± 95.31 | 176.77 ± 99.6 | 0.52 |
| Refractory | ||||||
| NLR | 4.66 ± 2.82 | 4.1 ± 2.56 | 0.03 | 4.1 ± 2.56 | 5.11 ± 3.09 | 0.006 |
| PLR | 186.18 ± 109.55 | 179.55 ± 105.55 | 0.601 | 179.55 ± 105.55 | 184.83 ± 98.89 | 0.749 |
Abbreviations: NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio.